🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess the relative bioavailabilit...
Status
Completed
Location
Teva Investigational Site 12141
Start Date
2025-03-10
Trial ID
NCT06911567
Treatments Being Tested
Clinical investigation of anti-psoriatic efficacy and atrophy...
Status
Completed
Location
proDERM GmbH
Start Date
2014-03
Trial ID
NCT02111499
Treatments Being Tested
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
This study is designed to assess bioequivalence between two products used f...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2011-02
Trial ID
NCT01322282
Treatments Being Tested
Aphasia is an acquired impairment of language, that commonly results from d...
Status
Recruiting
Location
University of Arizona
Start Date
2022-10-30
Trial ID
NCT05443633
Treatments Being Tested
This study was conducted to assess the bioequivalence of the ezetimibe tabl...
Status
Completed
Location
Clinical Research Center
Start Date
2017-12-17
Trial ID
NCT05681247
Treatments Being Tested
This post-market clinical study was designed to assess the safety and effec...
Status
Completed
Location
Basurto University Hospital
Start Date
2021-03-02
Trial ID
NCT07343973
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested